FNY Investment Advisers’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,500
Closed -$525K 870
2025
Q4
$525K Buy
+1,500
New +$507K 0.15% 138
2025
Q2
Sell
-1
Closed 1015
2025
Q1
$0 Sell
1
-1,148
-100% -$461K ﹤0.01% 789
2024
Q4
$423K Buy
+1,149
New +$481K 0.22% 93
2018
Q4
Sell
-200
Closed -$54K 776
2018
Q3
$54K Buy
+200
New +$51.9K 0.01% 359

Other funds holding ELV

FNY Investment Advisers's ELV Position: Q1 2026 in Review

FNY Investment Advisers sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 1,500 shares — an estimated $525K sold.

FNY Investment Advisers first reported a position in ELV in Q3 2018 and held it in 4 quarters. The position peaked at $525K in Q4 2025. 1,467 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • FNY Investment Advisers reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 1,500 Elevance Health shares in Q1 2026, an estimated $525K.
  • FNY Investment Advisers first reported a position in Elevance Health in Q3 2018 and held it in 4 quarters.
  • FNY Investment Advisers's Elevance Health position peaked at $525K in Q4 2025.
  • 1,467 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on FNY Investment Advisers's 13F filing for Q1 2026, filed 15 Apr 2026.